Randomized controlled trial of sirolimus conversion in cardiac transplant recipients with renal insufficiency

American Journal of Transplantation

Volumn 12, Issue 9, 2012, Pages 2487-2497

  Zuckermann, A ^a   Keogh, Anne ^b   Crespo Leiro, M G ^c   Mancini, D ^d   Vilchez, F González ^e   Almenar, L ^f   Brozena, S ^g   Eisen, H ^h   Tai, S See ⁱ   Kushwaha, S ^j  

^a UNIVERSITY OF VIENNA   (Austria)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY OF A CORUÑA   (Spain)

^d NewYork Presbyterian Hospital   (United States)

^e HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^f HOSPITAL UNIVERSITARIO LA FE   (Spain)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

ⁱ PFIZER INC   (United States)

^j MAYO CLINIC ROCHESTER   (United States)

more..

Author keywords

Cyclosporine; heart transplantation; immunosuppressive agents; renal failure; sirolimus; tacrolimus

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CREATININE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN;

ABDOMINAL PAIN; ACNE; ACUTE GRAFT REJECTION; ADULT; AGED; ANEMIA; ANGIONEUROTIC EDEMA; APHTHOUS STOMATITIS; ARTICLE; CARDIAC GRAFT REJECTION; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; COUGHING; CREATININE CLEARANCE; DIARRHEA; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; DYSPNEA; FEMALE; GASTROINTESTINAL CARCINOMA; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HEART ARRHYTHMIA; HEART TRANSPLANTATION; HERPES SIMPLEX; HERPES ZOSTER; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; MULTICENTER STUDY; NEOPLASM; PERIPHERAL EDEMA; PHARYNGITIS; PHASE 3 CLINICAL TRIAL; PHASE 4 CLINICAL TRIAL; PNEUMONIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN CARCINOMA; STOMATITIS; SURGICAL PATIENT; UPPER RESPIRATORY TRACT INFECTION; WOUND HEALING IMPAIRMENT;

AGED; FEMALE; GLOMERULAR FILTRATION RATE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; SIROLIMUS;

EID: 84865582428     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04131.x     Document Type: Article

References (24)

1. Ojo AO, Held PJ, Port FK, et al,. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349: 931-940. (Pubitemid 37064766)
2. van GT, Balk AH, Zietse R, Hesse C, Mochtar B, Weimar W,. Renal insufficiency after heart transplantation: A case-control study. Nephrol Dial Transplant 1998; 13: 2322-2326. (Pubitemid 28416560)
3. Taylor AL, Watson CJ, Bradley JA,. Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy. Crit Rev Oncol Hematol 2005; 56: 23-46. (Pubitemid 41278644)
4. Bloom RD, Reese PP,. Chronic kidney disease after nonrenal solid-organ transplantation. J Am Soc Nephrol 2007; 18: 3031-3041. (Pubitemid 350223963)
5. Kobashigawa JA,. Controversies in heart and lung transplantation immunosuppression: Tacrolimus versus cyclosporine. Transplant Proc 1998; 30: 1095-1097. (Pubitemid 28309497)
6. Zuckermann AO, Aliabadi AZ,. Calcineurin-inhibitor minimization protocols in heart transplantation. Transpl Int 2009; 22: 78-89.
7. Goldstein DJ, Zuech N, Sehgal V, Weinberg AD, Drusin R, Cohen D,. Cyclosporine-associated end-stage nephropathy after cardiac transplantation: Incidence and progression. Transplantation 1997; 63: 664-668. (Pubitemid 27132197)
8. Kushwaha SS, Khalpey Z, Frantz RP, et al,. Sirolimus in cardiac transplantation: Use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity. J Heart Lung Transplant 2005; 24: 2129-2136. (Pubitemid 41814736)
9. Raichlin E, Khalpey Z, Kremers W, et al,. Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients. Transplantation 2007; 84: 467-474. (Pubitemid 47312156)
10. Raichlin E, Bae JH, Khalpey Z, et al,. Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation. Circulation 2007; 116: 2726-2733. (Pubitemid 350291245)
11. Sehgal SN,. Rapamune (sirolimus, rapamycin): An overview and mechanism of action. Ther Drug Monit 1995; 17: 660-665.
12. Groetzner J, Kaczmarek I, Schulz U, et al,. Mycophenolate and sirolimus as calcineurin inhibitor-free immunosuppression improves renal function better than calcineurin inhibitor-reduction in late cardiac transplant recipients with chronic renal failure. Transplantation 2009; 87: 726-733.
13. Groetzner J, Meiser B, Landwehr P, et al,. Mycophenolate mofetil and sirolimus as calcineurin inhibitor-free immunosuppression for late cardiac-transplant recipients with chronic renal failure. Transplantation 2004; 77: 568-574. (Pubitemid 38282814)
14. Hunt J, Lerman M, Magee MJ, Dewey TM, Herbert M, Mack MJ,. Improvement of renal dysfunction by conversion from calcineurin inhibitors to sirolimus after heart transplantation. J Heart Lung Transplant 2005; 24: 1863-1867. (Pubitemid 41641863)
15. Sahin S, Gurkan A, Uyar M, et al,. Conversion to proliferation signal inhibitors-based immunosuppressive regimen in kidney transplantation: To whom and when? Transplant Proc 2011; 43: 837-840.
16. Holden JE, Kelley K, Agarwal R,. Analyzing change: A primer on multilevel models with applications to nephrology. Am J Nephrol 2008; 28: 792-801.
17. Littell RC, Milliken GA, Stroup WW, Wolfinger R,. SAS System for Mixed Models. Cary, NC: SAS Institute, Inc., 1996.
18. Hunt J, Bedanova H, Starling RC, et al,. Premature termination of a prospective, open label, randomized, multicenter study of sirolimus to replace calcineurin inhibitors (CNIs) in a standard care regimen of CNI, MMF and corticosteroids early after heart transplantation [abstract 398]. J Heart Lung Transplant 2007; 26: S203.
19. Bestetti R, Theodoropoulos TA, Burdmann EA, Filho MA, Cordeiro JA, Villafanha D,. Switch from calcineurin inhibitors to sirolimus-induced renal recovery in heart transplant recipients in the midterm follow-up. Transplantation 2006; 81: 692-696.
20. Aliabadi AZ, Mahr S, Dunkler D, et al,. Safety and efficacy of statin therapy in patients switched from cyclosporine to sirolimus after cardiac transplantation. Transplantation 2008; 86: 1771-1776.
21. Aliabadi AZ, Pohanka E, Seebacher G, et al,. Development of proteinuria after switch to sirolimus-based immunosuppression in long-term cardiac transplant patients. Am J Transplant 2008; 8: 854-861. (Pubitemid 351347752)
22. Al-Aly Z, Zeringue A, Fu J, et al,. Rate of kidney function decline associates with mortality. J Am Soc Nephrol 2010; 21: 1961-1969.
23. Matsushita K, Selvin E, Bash LD, Franceschini N, Astor BC, Coresh J,. Change in estimated GFR associates with coronary heart disease and mortality. J Am Soc Nephrol 2009; 20: 2617-2624.
24. Meier-Kriesche HU, Baliga R, Kaplan B,. Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation. Transplantation 2003; 75: 1291-1295. (Pubitemid 36513036)